Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates.

Slides:



Advertisements
Similar presentations
Chapter 19 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Advertisements

Tumors of Intestines.
Pathophysiology Colon CA. Most colorectal cancers, regardless of etiology, arise from adenomatous polyps. Polyp - a grossly visible protrusion from the.
Polyps – Where do they come from and what do you do with them?!
Eugen Divjak Mentor: A. Žmegač Horvat
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Colorectal Adenomas Santhat Nivatvongs MD Mayo Clinic Rochester Minnesota U. S.A.
The Adenoma/Carcinoma Sequence in the Colon
Assessment of Adenomas Geraint Williams Pathology Department Cardiff University.
Introduction to Neoplasia
GI TRACT SURGICAL PATHOLOGY Dr Rasti. Case 1:lower esopahgus mucosal biopsy (tubular esophagus )
Colorectal Cancer Ramon Garza III, M.D.. Colorectal CA DNA Sequencing Mismatch Repair Genes Genomics Role of PCR and FISH in Colon CA.
Hereditary Colon Cancer ACP, October 2013 Steve Lanspa MD, FACP.
Mechanisms and Epidemiology of Colon Cancer
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Hereditary tumours to be aware of Gerd JACOMEN Dept. of Pathology.
Is Your Patient At Risk of Having Lynch Syndrome? David Strassler, MD Martin’s Point Health Care Biddeford, Maine
Colorectal cancer PathogenesisBy Dr. Fahd Al-Mulla.
Neoplasia Lecture 2 Dr. Maha Arafah.
Joint Hospital Surgical Grand Round 19 June 2004.
Tumors of the small and large intestines Maha Arafah.
Reporting and Management of Early stage Colorectal Cancer Frank Carey Dundee.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Genetics & Colorectal Cancer
Building a Model of Tumorigenesis: A small group activity for a Cancer Biology/Cell Biology course L. K. Wright Supplemental File : Multistep Tumorigenesis.
大肠癌及其癌前病变 Colorectal Carcinoma and Its Precursor Lesions
Colorectal carcinoma Dr.Mohammadzadeh.
NEOPLASIA Nadia Ismiil, MD, FRCPC.
Tutorial on Breast Pathology Part I: Ductal and Lobular Neoplasias Thomas J Lawton MD, Director Seattle Breast Pathology Consultants, LLC Seattle, WA.
Colon Cancer. Epidemiology 3 rd most common cancer in males and females. Accounts for 11% of cancer deaths. In 2000, 130,200 cases (colon and rectum).
Handling difficult cases and possible referral service Professor Neil A Shepherd Gloucester, UK NHSBCSP Pathology Day, London, November 21, 2007.
G ASTROINTESTINAL B LOCK P ATHOLOGY LECTURE 2014 Dr. Maha Arafah Dr. Ahmed Al Humaidi Benign Tumors of Intestine.
Colorectal Cancer. Colorectal cancer - statistics Leading causes of cancer death in the US Male Female Lung – 31% Lung – 25% Prostate – 11% Breast – 11%
Abdulmalik Alsheikh, MD, FRCPC Maha Arafah, MBBS, KSFP
NEOPLASMS OF THE STOMACH
Colon polyps Peter Stanich, MD
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
Serrated Polyps of the Colon Aaron Sinclair, MD University of Kansas School of Medicine – Wichita Department of Family and Community Medicine Wesley Family.
Neoplasia Lecture 2 Maha Arafah,MD,KSFP Abdulmalik Alsheikh, MD, FRCPC CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS EPIDEMIOLOGY CHARACTERISTICS OF.
Neoplasia Lecture 2 Abdulmalik Alsheikh, MD, FRCPC Maha Arafah, MBBS, KSFP Abdulmalik Alsheikh, MD, FRCPC Maha Arafah, MBBS, KSFP CHARACTERISTICS OF BENIGN.
NEOPLASIA CASES. CASE 1 A 20 year old female presented with a round mobile breast lump. She has no family history of breast cancer Question : What test.
Endometrial polyp, hyperplasia, carcinoma Dr: Salah Ahmed.
NEOPLASIA Dr. Manal Maher Hussein.
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
GI conference Case 3 Stomach and liver F/69 S
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Pathologic Diagnosis of Gastric Epithelial Neoplasia 2008 년도 2 학기 의학과 석. 박사 공통과목 위장관의 외과병리.
Adenoma of the ampulla of vater
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Endomicroscopy is born—do we still need the pathologist?
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Irritable Bowel Syndrome
Gastrointestinal Block Pathology lecture 2016/2017
GIT BLOCK PATHOLOGY PRACTICAL Dr Abdullah Basabein
Jasper Vleugels PhD-student AMC
FAMILIAL ADENOMATOUS POLYPOSIS
A Visual Tour of Effective Colonoscopy
Preinvasive Neoplasia in the Stomach: Diagnosis and Treatment
The Malignant Colon Polyp: Diagnosis and Therapeutic Recommendations
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Polyps of the Colon and Rectum
A Visual Tour of Effective Colonoscopy
Beyond Standard Image-enhanced Endoscopy Confocal Endomicroscopy
Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
Christopher G. Chapman, MD, Irving Waxman, MD, FASGE  VideoGIE 
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease  Francis A. Farraye, Robert D. Odze, Jayne.
Colonic polyps and tumors
Dr. Maha Arafah Dr. Ahmed Al Humaidi
Presentation transcript:

Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates

► Disclosure:  I have no financial disclosures to make.  I will suggest texts and websites for reference and study, but receive no financial gain from these.

Colonic Adenomas ► Benign premalignant proliferation of colonic epithelium—all have dysplasia (low grade) and are dysplastic. ► Precursor lesions to colorectal carcinoma.

Classification ► Tubular: less than 25% villous ► TVA: between 20-80% villous ► Villous Adenoma:  Less than 5% of adenomas  More than 30% have high grade dysplasia  2% have carcinoma

Low grade dysplasia

Colonic Adenomas ► 60-70% of all endoscopically removed colonic polyps ► Lifetime prevalence: % ► 50% increase in size with time ► Only some (5-10%) progress to carcinoma ► 3-5% have invasive carcinoma at diagnosis ► Size of adenoma is BEST predictor of carcinoma risk ► High grade dysplasia and villous component more likely with increase in size of polyp

Chromosomal Instability Pathway

High Grade Dysplasia ► Also known as carcinoma in situ ► Present in 5-7 % of adenomas at initial diagnosis ► More likely if:  villous  larger (>1cm)  older than 60 yrs

Intramucosal Carcinoma ► Neoplastic cells extend through gland basement membrane and into lamina propria BUT NOT through muscularis mucosae. ► NOT shown to have metastatic risk:  Paucity of lymphatics in colonic mucosa  Classified same as high grade in TNM

Pseudoinvasion in Adenomas ► Misplaced or herniated epithelium in submucosa. ► Can be mistaken for invasive carcinoma ► Most in left colon, particularly sigmoid— almost never seen proximal to transverse colon ► Pedunculated polyps, more than 1 cm with at least 1 cm stalk. ► Peristalsis related torsion/twisting

Adenoma with Invasive Adenocarcinoma

Distinguishing Pseudoinvasion vs. Invasion 1. Compare the epithelium to epithelium you are confident is adenoma in the same polyp. 2. Compare the stroma to stroma you are confident is the benign stroma of adenoma in the same polyp. 3. Look for evidence of definite vascular or lymphatic space invasion. 4. Cut levels. This will at least buy you a little time, and you may find more definitive evidence of submucosal invasion in the deeper sections. 1. Compare the epithelium to epithelium you are confident is adenoma in the same polyp. 2. Compare the stroma to stroma you are confident is the benign stroma of adenoma in the same polyp. 3. Look for evidence of definite vascular or lymphatic space invasion. 4. Cut levels. This will at least buy you a little time, and you may find more definitive evidence of submucosal invasion in the deeper sections. Yerian, L USCAP short course

-You can call the clinician to discuss the endoscopic findings and management plan. -Benign misplaced epithelium is uncommon in sessile lesions. If the polyp was not completely excised and is not endoscopically resectable, then the patient may need to undergo a resection irrespective of your assessment of the submucosal epithelium. Yerian, L USCAP 2010 Short course

Pseudoinvasion ► Occasionally a definite distinction between invasion and pseudoinvasion is not possible and consensus cannot be reached, even among experienced GI paths ► Giving a descriptive diagnosis is best and a phone call to the clinician may be helpful. The pathologist may choose to describe the finding ("deep neoplastic glands of uncertain significance"), and elaborate in a comment as to the diagnostic problems. ► Yerian, L USCAP 2010 short course

Carcinomas arising in Adenomas ► ► Surgical resection if:   Poorly differentiated   at or near margin   lymphovascular invasion ► ► Endoscopic polypectomy is adequate if:   carcinoma is low grade (well or moderately differentiated)   margin is free or carcinoma, more than 1 cm away from margin   no evidence of lymphovascular invasion

-Up to 30% in asxs adults over 50 y/o -Prevalence increases with age -Usually less than 5mm -Smooth, sessile -Typically do not increase in size with time (left sided)

Serrated Adenomas ► Controversial entity only recently recognized (1990) as a pathologic lesion distinct from hyperplastic polyps ► Recognition due to:  Pts with hyperplastic polyposis have an increased risk for neoplasia  Sporadic right-sided hyperplastic polyps more commonly contain a variety of genetic alterations NOT present in left-sided counterparts

Serrated adenomas ► Formal evaluation of their clinical features and incidence is lacking due to discrepancies in literature in terms of nomenclature--called by numerous names ► Are thought to represent 20% of all lesions with serrated architecture encountered at endoscopy

Serrated adenomas: Facts ► Epithelial neoplasm with a distinctive serrated architecture associated with abnormal proliferation and associated risk for colorectal neoplasia ► Slightly more common in left colon  If Small, endoscopic removal ► In right side:  Large (more than 1cm), flat  Remove entirely  Can present as an enlarged fold

Serrated polyp neoplasia pathway ► Proposed to represent an alternative molecular pathway to colorectal cancer ► Hp-- > atypical HP-- > serrated adenoma -- > cancer -- > cancer ► Predominant carcinomas of this pathway: show defective DNA mismatch repair (MMR)—can be MSI high or low ► 10 to 15% of all colorectal cancers

MSI and Cancer ► MSI is a key factor in several cancers including colorectal, endometrial, ovarian and gastric cancers. Colorectal cancer studies have demonstrated two mechanisms for MSI occurrence. ► The first is in hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch Syndrome, where an inherited mutation in a mismatch-repair gene causes a microsatellite repeat replication error to go unfixed. ► The second mechanism whereby MSI causes colorectal cancer is an epigenetic change which silences an essential mismatch-repair gene. ► In both cases, microsatellite insertions and deletions within tumor suppressor gene coding regions result in uncontrolled cell division and tumor growth.

Traditional serrated, usually left-sided

Eosinophilic cytoplasm

Sessile serrated adenoma, right-sided

Sessisle serrated adenoma, right-sided

Neoplasia in serrated polyp pathway ► Most if not all sporadic MSI carcinomas have a serrated histogenesis ► Epidemiological association with smoking but typical in elderly females ► Can have several histologic patterns:  Well to poorly differentiated  Undifferentiated  Lymphocytic response

-lymphocytic infiltrate -solid -signet ring cells -mucinous